NEXCELOM BIOSCIENCE
Nexcelom Bioscience is a biotechnology company providing cell counting, image cytometry, and image analysis services. Nexcelom offers different Cellometer models to count and analyze cell lines and primary cells, through a bright field and fluorescence imaging modes. Also, Celigo is powerful in high image quality, high throughput image cytometry system for adherent and suspension cells in microwell plates.
NEXCELOM BIOSCIENCE
Industry:
Biotechnology Medical Medical Device
Founded:
2003-01-01
Address:
Lawrence, Massachusetts, United States
Country:
United States
Website Url:
http://www.nexcelom.com
Total Employee:
101+
Status:
Active
Contact:
978.327.5340
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Founder
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Private Equity Round - Nexcelom Bioscience
Official Site Inspections
http://www.nexcelom.com Semrush global rank: 2.04 M Semrush visits lastest month: 10.29 K
- Host name: ae922f709288258ef.awsglobalaccelerator.com
- IP address: 13.248.249.39
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Nexcelom Bioscience"
Nexcelom Bioscience - Crunchbase Company Profile
Nexcelom Bioscience is a biotechnology company providing cell counting, image cytometry, and image analysis services. Nexcelom offers different Cellometer models to count and analyze cell lines and primary cells, through a bright field …See details»
Revvity, Inc. - PerkinElmer Expands Cell Biology Leadership with ...
May 12, 2021 · WALTHAM, Mass. -- (BUSINESS WIRE)--May 12, 2021-- PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom …See details»
Nexcelom Bioscience Company Profile 2024: Valuation, Investors ...
Manufacturer of cytometry products for cell analysis in life science and biomedical research.See details»
Nexcelom Bioscience LLC - Devex
With multiple patents pending, Nexcelom is a clear leader and innovator in the field of image-based cytometry for cell analysis. Learn more about Nexcelom Bioscience LLC's jobs, projects,...See details»
Nexcelom | Ampersand
Building on this momentum, Nexcelom welcomed significant organizational growth in 2019 with the addition of a VP of Marketing and a VP of Sales to expand the leadership team. It also …See details»
Nexcelom - LinkedIn
Pioneers in Automated Cell Counting and Analysis | Nexcelom Bioscience, now part of Revvity, is a developer and marketer of image cytometry products for cell analysis in life science and...See details»
PerkinElmer acquires Nexcelom Bioscience - 2021-05-13
May 13, 2021 · Nexcelom Bioscience Nexcelom Bioscience is a biotechnology company providing cell counting, image cytometry, and image analysis services. Acquiring Organization: …See details»
About Nexcelom Bioscience - cellacacytometry.net
With multiple patents pending, Nexcelom is a clear leader and innovator in the field of image-based cytometry for cell analysis. Thousands of customers, including the top ten …See details»
PerkinElmer Expands Cell Biology Leadership
May 18, 2021 · PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.See details»
PerkinElmer Expands Cell Biology Leadership with …
May 13, 2021 · WALTHAM, Mass.-- (BUSINESS WIRE)--May 12, 2021-- PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The …See details»
PerkinElmer set to acquire Nexcelom Bioscience for $260m
PerkinElmer will bolster its preclinical portfolio and cell and gene therapy manufacturing capabilities through the acquisition of Nexcelom. PerkinElmer will pay $260 million in cash, …See details»
PerkinElmer Expands Cell Biology Leadership with Agreement to …
May 12, 2021 · Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for …See details»
PerkinElmer Expands Cell Biology Capabilities with Nexcelom
Jun 1, 2021 · PerkinElmer has entered into an agreement to acquire Nexcelom Bioscience, a US-based provider of image cytometry products for cell analysis, for $260 Million in cash. The …See details»
Nexcelom - LinkedIn
Nexcelom | 13,093 followers on LinkedIn. Pioneers in Automated Cell Counting and Analysis | Nexcelom Bioscience, now part of Revvity, is a developer and marketer of image cytometry …See details»
PerkinElmer Picks Up Nexcelom for $260 Million to Expedite
PerkinElmer, Inc. continues to expand its presence in cell biology with the $260 million acquisition of Nexcelom Bioscience, a Massachusetts-based company with approximately 130 employees …See details»
PerkinElmer To Acquire Nexcelom Bioscience For $260M - Yahoo …
May 13, 2021 · Nexcelom provides automated cell counting and imaging products along with assays, cell reagents, and consumables. The acquisition enhances PerkinElmer’s preclinical …See details»
PerkinElmer To Acquire Nexcelom Bioscience For $260M
May 13, 2021 · Nexcelom provides automated cell counting and imaging products along with assays, cell reagents, and consumables. The acquisition enhances PerkinElmer’s preclinical …See details»
Nexcelom Bioscience - Contacts, Employees, Board Members
Nexcelom Bioscience is a biotechnology company providing cell counting, image cytometry, and image analysis services.See details»
PerkinElmer Buys Nexcelom Bioscience For $260 Mln - Nasdaq
May 12, 2021 · (RTTNews) - PerkinElmer, Inc. (PKI) Wednesday said it has acquired Nexcelom Bioscience for $260 million in cash. The transaction is expected to close during the second …See details»
Working at Nexcelom: 14 Reviews - Indeed
Oct 15, 2024 · Reviews from Nexcelom employees about Nexcelom culture, salaries, benefits, work-life balance, management, job security, and more.See details»